David Suhy was a biotechnology researcher and gene-therapy executive who co-founded Earli and served as its chief scientific officer. His work focused on genetic-vector technologies for cancer detection, imaging, and treatment, following scientific leadership roles at Benitec Biopharma and Tacere Therapeutics.
David Suhy was a biotechnology researcher and gene-therapy executive who co-founded Earli and served as its chief scientific officer. His work focused on genetic-vector technologies for cancer detection, imaging, and treatment, following scientific leadership roles at Benitec Biopharma and Tacere Therapeutics.
Career
Co-founder and Chief Scientific Officer at Earli from 2018-06 to 2026Led scientific development of genetic-vector technologies designed to make cancers produce detectable synthetic biomarkers. Helped build Earli’s science team and advance approaches for cancer detection, imaging, and treatment.